CLARITY MEDICAL GROUP HOLDING LIMITED Clarity Medical Group Holding Limited Stock
Equities
1406
KYG2181S1084
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.52 HKD | -1.89% |
|
-3.70% | -17.46% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 225M 28.87M | Sales 2023 | 214M 27.41M | Capitalization | 496M 63.63M |
|---|---|---|---|---|---|
| Net income 2022 | 13M 1.67M | Net income 2023 | -3M -385K | EV / Sales 2022 | 1.85 x |
| Net cash position 2022 | 221M 28.34M | Net cash position 2023 | 160M 20.54M | EV / Sales 2023 | 1.57 x |
| P/E ratio 2022 |
36.2
x | P/E ratio 2023 |
-154
x | Employees | 135 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 34.73% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.89% | ||
| 1 week | -3.70% | ||
| Current month | -3.70% | ||
| 1 month | -5.45% | ||
| 3 months | +4.00% | ||
| 6 months | -10.34% | ||
| Current year | -17.46% |
1 week
0.51
0.56
1 month
0.510.63
Current year
0.400.77
1 year
0.401.08
3 years
0.401.61
5 years
0.401.61
10 years
0.401.61
| Managers | Title | Age | Since |
|---|---|---|---|
Yung Hui
CEO | Chief Executive Officer | 55 | 19-03-28 |
Tsz Hong Lo
BRD | Director/Board Member | 46 | 19-03-19 |
Fan Chan
HRO | Human Resources Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wai Hung Ma
BRD | Director/Board Member | 59 | 21-05-05 |
Ting Yuk Wu
CHM | Chairman | 69 | 19-03-19 |
Yung Hui
CEO | Chief Executive Officer | 55 | 19-03-28 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 0.52 | -1.89% | 301,250 |
| 24-05-16 | 0.53 | 0.00% | 27,500 |
| 24-05-14 | 0.53 | -5.36% | 200,000 |
| 24-05-13 | 0.56 | +3.70% | 141,250 |
| 24-05-10 | 0.54 | 0.00% | 123,750 |
Delayed Quote Hong Kong S.E., May 17, 2024 at 04:08 am EDT
More quotes
Clarity Medical Group Holding Ltd is an investment holding company mainly engaged in the provision of ophthalmic consultation and treatment services. The Company mainly provides refractive treatment services including Smile surgeries, multifocal IOL (intraocular lens) replacements and ICL (implantable contact lens) implantations. In addition, the Company also provides treatments for other eye problems, such as standard cataract surgeries, laser procedures, PPV (pars-plana vitrectomy) surgeries, other treatments and surgeries, medical consultation and examination services and sales of prescriptions and others.
Calendar
2024-06-24
- Q4 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -17.46% | 35.87M | |
| -18.52% | 16.2B | |
| +5.41% | 12.73B | |
| +3.98% | 11.68B | |
| +4.36% | 10.22B | |
| +28.07% | 8.6B | |
| -4.98% | 7.78B | |
| +6.76% | 6.73B | |
| +7.33% | 6.4B | |
| +48.17% | 4.49B |
- Stock Market
- Equities
- 1406 Stock
